➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
Dow
Johnson and Johnson
Baxter
McKinsey

Last Updated: September 18, 2020

DrugPatentWatch Database Preview

Litigation Details for ViiV Healthcare Company v. Gilead Sciences, Inc. (D. Del. 2018)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

ViiV Healthcare Company v. Gilead Sciences, Inc. (D. Del. 2018)

Docket   Start Trial Date Filed 2018-02-07
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Colm Felix Connolly
Jury Demand Plaintiff Referred To Christopher J. Burke
Parties BAYER AG
Patents 10,092,009; 10,184,001; 7,015,018; 7,262,019; 8,008,003; 8,063,015; 8,129,385; 9,000,002; 9,006,224; 9,010,165; 9,022,022; 9,127,013; 9,297,018
Attorneys Michael P. Stadnick
Firms Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in ViiV Healthcare Company v. Gilead Sciences, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in ViiV Healthcare Company v. Gilead Sciences, Inc.

Details for ViiV Healthcare Company v. Gilead Sciences, Inc. (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
2020-02-05 174 Opinion - Memorandum Opinion infringing United States Patent Number 8,129,385 (the #385 patent). The #385 patent covers pharmaceutical…principle of patent law that the claims of a 2 patent define the…requirements for a patent.") ( citation omitted). It is the claims-not the patent's written description…Bictegravir infringes claims 2 and 6 of the #3 85 patent under the doctrine of equivalents. That doctrine… literally infringe upon the express terms of a patent claim may nonetheless be found to infringe if External link to document
2020-02-10 176 Notice of Service Dobkin, M.D. Regarding Infringement of U.S. Patent No. 8,129,385; (3) Reply Expert Report of Jennifer Dressman…Guengerich, Ph.D., Regarding Infringement of U.S. Patent No. 8,129,385; (6) Reply Expert Report of Kenneth M. Merz…Gilead Sciences, Inc.s Infringement of U.S. Patent No. 8,129,385; (7) Supplemental Reply Expert Report of…Gilead Sciences, Inc.s Infringement of U.S. Patent No. 8,129,385; (8) Expert Report of Timothy Simcoe, Ph.D…Gilead Sciences, Inc.s Infringement of U.S. Patent No. 8,129,385 filed by Shionogi & Co., Ltd., ViiV Healthcare External link to document
2018-02-07 3 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,129,385. (crb) (Entered: … 7 February 2018 1:18-cv-00224 Patent Plaintiff District Court, D. Delaware External link to document
2020-06-24 303 Redacted Document 0.7* (2.6) 4.2 ⫾ 0.9* (2.8) 4.2 ⫾ 1.3* (2.8) 8.3 ⫾ 1.4* (5.5) 6.4 ⫾ 1.6* (4.3) DTG … 7 February 2018 1:18-cv-00224 Patent Plaintiff District Court, D. Delaware External link to document
2020-06-24 304 Redacted Document lt;Q> 136:10 141:2 123:1, 5, 9, 10, 92:9 93:11, 15 232:3 245:23 Q148H 146:22, …is Robert Craigie? 22 provisional patent application. 23 A. He's another… panel 49:12 225:2 236:12 patent 113:22 overstatement 148:25 211:16 … 7 February 2018 1:18-cv-00224 Patent Plaintiff District Court, D. Delaware External link to document
2020-07-06 313 Order - -Memorandum and Order judgment on the basis that claim 6 of U.S. Patent No. 8,129,385 specifically excludes compounds with bicyclic… 7 February 2018 1:18-cv-00224 Patent Plaintiff District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Baxter
AstraZeneca
Johnson and Johnson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.